Document is current
Any future updates will be listed below
-
Authors
Balogh, Fruzsina https://orcid.org/0000-0003-4623-4024
Angyal, Dorottya https://orcid.org/0009-0003-0900-1966
Gonczi, Lorant https://orcid.org/0000-0002-8819-6460
Lontai, Livia https://orcid.org/0000-0001-6087-7398
Lakatos, Peter L. https://orcid.org/0000-0002-3948-6488
Ilias, Akos https://orcid.org/0000-0002-9865-2642
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 23 December 2025
First Online: 4 February 2026
Declarations
:
: Written informed consent was obtained from the patient for publication of this case report. Written informed consent was obtained from participants (or their parents/legal guardians/next-of-kin) for publication of the details of their medical case and any accompanying images. Ethical approval is not required for this study in accordance with local or national guidelines.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: PLL has been a speaker and/or advisory board member: AbbVie, Amgen, Bristol Myers Squibb, Celltrion, Fresenius Kabi, Gilead, Janssen, Eli Lilly, Merck, Organon, Pendopharm, Pfizer, Roche, Sandoz, and Takeda and has received unrestricted research grants from AbbVie, Gilead, and Pfizer. AI has been a speaker for Janssen and AbbVie. All remaining authors have no further competing of interest.
